US FDA Modifies Fact Sheet of Johnson & Johnson to Include Rare Bleeding Disorder
The Food and Drug Administration (FDA) of the United States has been modifying the fact sheet for the novel corona virus vaccine of Johnson & Johnson for the purpose of including a rare risk of the immune thrombocytopenia, which is a rare bleeding disorder. The US FDA said that, the reports of the adverse events […]
Continue Reading